| Product NDC: | 0338-5003 |
| Proprietary Name: | Ceftriaxone |
| Non Proprietary Name: | Ceftriaxone Sodium |
| Active Ingredient(s): | 2 g/50mL & nbsp; Ceftriaxone Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0338-5003 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065224 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110923 |
| Package NDC: | 0338-5003-41 |
| Package Description: | 24 BAG in 1 CARTON (0338-5003-41) > 50 mL in 1 BAG |
| NDC Code | 0338-5003-41 |
| Proprietary Name | Ceftriaxone |
| Package Description | 24 BAG in 1 CARTON (0338-5003-41) > 50 mL in 1 BAG |
| Product NDC | 0338-5003 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ceftriaxone Sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110923 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | CEFTRIAXONE SODIUM |
| Strength Number | 2 |
| Strength Unit | g/50mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |